Adicet Bio Inc (ACET)
1.31
+0.05
(+3.97%)
USD |
NASDAQ |
Nov 05, 16:00
1.31
0.00 (0.00%)
After-Hours: 18:13
Adicet Bio Price: 1.31 for Nov. 5, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Nov 04, 2024 | 1.25 | 1.30 | 1.20 | 1.26 | 474103.0 |
Nov 01, 2024 | 1.30 | 1.30 | 1.25 | 1.25 | 246948.0 |
Oct 31, 2024 | 1.38 | 1.42 | 1.26 | 1.28 | 291043.0 |
Oct 30, 2024 | 1.40 | 1.43 | 1.35 | 1.36 | 261756.0 |
Oct 29, 2024 | 1.43 | 1.45 | 1.41 | 1.41 | 158061.0 |
Oct 28, 2024 | 1.41 | 1.48 | 1.41 | 1.43 | 161106.0 |
Oct 25, 2024 | 1.41 | 1.46 | 1.40 | 1.40 | 118136.0 |
Oct 24, 2024 | 1.46 | 1.46 | 1.40 | 1.42 | 180255.0 |
Oct 23, 2024 | 1.50 | 1.52 | 1.425 | 1.44 | 181228.0 |
Oct 22, 2024 | 1.46 | 1.54 | 1.46 | 1.52 | 316411.0 |
Oct 21, 2024 | 1.46 | 1.51 | 1.42 | 1.49 | 238301.0 |
Oct 18, 2024 | 1.46 | 1.51 | 1.45 | 1.45 | 178630.0 |
Oct 17, 2024 | 1.50 | 1.50 | 1.45 | 1.48 | 201337.0 |
Oct 16, 2024 | 1.44 | 1.51 | 1.39 | 1.49 | 555961.0 |
Oct 15, 2024 | 1.38 | 1.42 | 1.38 | 1.40 | 207287.0 |
Oct 14, 2024 | 1.39 | 1.40 | 1.36 | 1.38 | 236066.0 |
Oct 11, 2024 | 1.41 | 1.44 | 1.36 | 1.39 | 244079.0 |
Oct 10, 2024 | 1.41 | 1.445 | 1.37 | 1.40 | 253701.0 |
Oct 09, 2024 | 1.44 | 1.44 | 1.40 | 1.42 | 226077.0 |
Oct 08, 2024 | 1.410 | 1.46 | 1.39 | 1.43 | 208053.0 |
Oct 07, 2024 | 1.42 | 1.49 | 1.38 | 1.41 | 190711.0 |
Oct 04, 2024 | 1.42 | 1.45 | 1.40 | 1.42 | 122360.0 |
Oct 03, 2024 | 1.47 | 1.47 | 1.39 | 1.42 | 246766.0 |
Oct 02, 2024 | 1.40 | 1.50 | 1.37 | 1.49 | 2.506M |
Oct 01, 2024 | 1.41 | 1.50 | 1.395 | 1.42 | 2.597M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.07
Minimum
Jul 05 2024
64.89
Maximum
Nov 12 2019
9.497
Average
9.31
Median
Dec 26 2019
Price Benchmarks
CEL-SCI Corp | 0.7953 |
AIM ImmunoTech Inc | 0.2479 |
IGC Pharma Inc | 0.38 |
NovaBay Pharmaceuticals Inc | 0.77 |
Protalix BioTherapeutics Inc | 1.29 |
Price Related Metrics
PS Ratio | 2.165 |
Price to Book Value | 0.4591 |
Earnings Yield | -192.4% |
Market Cap | 107.95M |